Supplementary Material - FNE

Table S1: Full chart of included studies reporting facial and/or neck erythema with dupilumab use Table S2: Quality assessment for case reports/series Table S3: Funding sources of included studies References Prospero protocol PRISMA checklist表S1：报告使用度普利尤单抗（dupilumab）期间面部和/或颈部红斑的纳入研究完整一览表 表S2：病例报告和病例系列研究的质量评价表 表S3：纳入研究的资助来源 参考文献 Prospero注册方案 PRISMA检查表